The Effect of Local Melatonin Application Around Immediately Placed Implants in the Maxillary Premolar

NCT ID: NCT07103564

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Immediate implants provide ideal three-dimensional positioning compared to conventional implants. There may be a gap between the surface of the implant and the bone walls of the socket when it is inserted into a recently extracted alveolus. To compensate for this, various grafting materials are used. Recently, melatonin has gained significant attention because of its inhibitory action on bone resorption through upregulating the expression of osteoprotegerin, which acts as a decoy receptor for RANKL and inhibits its binding to osteoclast precursors thereby inhibiting osteoclast formation and activity. So, we will conduct this study to evaluate the effects of local melatonin application around immediately placed implants.

Aim of the study: To evaluate the effectiveness of adding local melatonin around immediately placed implants in maxillary premolars.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Implants Osteoprotegerin Melatonin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

melatonin therapy

Group Type EXPERIMENTAL

Immediately placed implant in maxillary premolars with local melatonin application

Intervention Type OTHER

Patients will receive immediately placed implants with local melatonin powder (3mg) application.

No melatonin

Group Type ACTIVE_COMPARATOR

Immediately placed implant in maxillary premolars without local melatonin application

Intervention Type OTHER

Patients will receive immediately placed implants without local melatonin application.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Immediately placed implant in maxillary premolars with local melatonin application

Patients will receive immediately placed implants with local melatonin powder (3mg) application.

Intervention Type OTHER

Immediately placed implant in maxillary premolars without local melatonin application

Patients will receive immediately placed implants without local melatonin application.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with non-restorable maxillary premolars with sufficient bone quantity to receive the dental implant without the need for bone graft.
* Patients with no local or systemic pathology that can interfere with normal wound healing.
* Non-smokers.
* Patients who are properly motivated to complete follow-up visits

Exclusion Criteria

* Patients with uncontrolled medical conditions that can affect surgical outcome or bone and wound healing. (ex: uncontrolled diabetes mellitus)
* Patients with periapical pathology that may contraindicate immediate implant placement.
* History of receiving irradiation in the head and neck region
Minimum Eligible Age

25 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hams Hamed Abdelrahman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hams Hamed Abdelrahman

Lecturer of Dental Public Health and biostatistical consultanat

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University

Alexandria, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0812-12/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Osteoimplant and Bone Healing
NCT06664060 NOT_YET_RECRUITING EARLY_PHASE1
Osteoimplant and Dental Implants Stability
NCT06657521 NOT_YET_RECRUITING EARLY_PHASE1